Targeted therapies for resectable lung adenocarcinoma: ADAURA opens for thoracic oncologic surgeons Editorial
| Authors: | Jones, D. R.; Wu, Y. L.; Tsuboi, M.; Herbst, R. S. |
| Title: | Targeted therapies for resectable lung adenocarcinoma: ADAURA opens for thoracic oncologic surgeons |
| Keywords: | cancer chemotherapy; cancer survival; cancer surgery; overall survival; gene deletion; cancer recurrence; cisplatin; erlotinib; drug safety; treatment duration; drug approval; disease free survival; cancer staging; medical decision making; metastasis; epidermal growth factor receptor; editorial; cancer research; lung adenocarcinoma; adjuvant chemotherapy; surgeon; gefitinib; clinical effectiveness; neoadjuvant chemotherapy; egfr; point mutation; lung surgery; genetic screening; lobectomy; randomized controlled trial (topic); clinical trial (topic); molecularly targeted therapy; human; osimertinib; vinorelbine tartrate; adaura |
| Journal Title: | Journal of Thoracic and Cardiovascular Surgery |
| Volume: | 162 |
| Issue: | 1 |
| ISSN: | 0022-5223 |
| Publisher: | Mosby Elsevier |
| Date Published: | 2021-07-01 |
| Start Page: | 288 |
| End Page: | 292 |
| Language: | English |
| DOI: | 10.1016/j.jtcvs.2021.02.008 |
| PUBMED: | 33691940 |
| PROVIDER: | scopus |
| PMCID: | PMC8519337 |
| DOI/URL: | |
| Notes: | Editorial -- Export Date: 1 July 2021 -- Source: Scopus |
